• Title of article

    Antibacterial and antioxidant activity of catechin, gallic acid, and epigallocatechin-3-gallate: focus on nanoformulations

  • Author/Authors

    Alavi ، Mehran Department of biological science - Faculty of Science - Kurdistan University , Hamblin ، Michael Wellman Centre for Photomedicine - Massachusetts General Hospital , Aghaie ، Ermia High Performance Powertrain Materials Laboratory - School of Engineering - University of British Columbia - Okanagan , Mousavi ، Ali Reza Department of Neuroscience - Dorris Neuroscience Center - Scripps Research Institute , Hajimolaali ، Mohammad Department of Drug and Food Control - Faculty of Pharmacy - Tehran University of Medical Sciences

  • From page
    62
  • To page
    72
  • Abstract
    Up to one million secondary metabolites are found in plant species, some of which may have desirable therapeutic activities. Among these secondary metabolites, catechin, gallic acid, and epigallocatechin-3-gallate are natural phenolic compounds with promising antioxidant and antibacterial activity. However, these compounds have disadvantages of poor solubility, low bioavailability in physiological conditions, and side effects in patients. Therefore new strategies could rely on formulations with other synthetic and natural materials. Nanoformulations of secondary metabolites could be new efficient strategies to treat many chronic bacterial infections. Combinations and conjugates of catechin, gallic acid, and epigallocatechin-3-gallate with various antibiotics could reduce the dose of these compounds, increase their antibacterial activity, and decrease cytotoxicity against healthy cells. For instance, a smart combination of two or more secondary metabolites may improve therapeutic applications in physiological conditions. In this regard, the growth of antibiotic-resistant bacteria, specifically multidrug-resistant bacteria with overexpression of efflux pumps and expression of the penicillinase enzyme, has been inhibited significantly. According to recent investigations, this review will discuss the advances and challenges of new micro and nanoformulations of these natural products.
  • Keywords
    Secondary metabolites , Natural phenolic compounds , Low bioavailability , Antibacterial Activity , Nanomaterials , Combination therapy
  • Journal title
    Cellular, Molecular and Biomedical Reports
  • Journal title
    Cellular, Molecular and Biomedical Reports
  • Record number

    2737830